UK health services: latest news

UK health services resources

UK health services features

UK health services in your own words

UK health services news from aidsmap

More news

UK health services news selected from other sources

  • 'Give HIV drugs to healthy gay men'

    Healthy gay men should be offered daily HIV drugs to prevent infections, say UK Medical Research Council and Public Health England scientists. Their study, on 545 high-risk men, found one case of HIV could be stopped for every 13 men treated for a year. The research team says it would be similar to the pill for women and would not encourage risky sex. The findings have been described as a "game changer" and the NHS is considering how to adopt them.

    25 February 2015 | BBC News
  • Dover Health Centre displays 'offensive' sign turning away gay men

    An NHS trust has apologised after a health centre displayed an "offensive" notice turning away gay men. The clinic had a sign stating that patients who had been sexually assaulted, who are male and have sex with men, or sex workers could not be tested there.

    13 February 2015 | Kent Online
  • London HIV Prevention Programme media contracts announced

    Contracts have been awarded to a group of specialist media agencies (Team Enter, Manning Gottlieb, Carat) as part of the new London HIV Prevention Programme (LHPP) funded by London boroughs.

    21 January 2015 | London Councils
  • Hepatitis C drug delayed by NHS due to high cost

    The NHS is to delay the introduction of a highly expensive drug that can save the lives of people infected with the hepatitis C virus. The move by NHS England is unprecedented, because the NHS rationing body, Nice (the National Institute for Health and Care Excellence) has approved the drug. Nice says sofosbuvir is cost-effective, because it is a cure for people who would otherwise run up huge NHS bills.

    16 January 2015 | The Guardian
  • Dolutegravir and Truimeq approved in England: London guidelines updated

    On 14 January 2015, NHS England published the long awaited policy on dolutegravir and the fixed dose combination (FDC) of dolutegravir/abacavir/3TC (Triumeq). The London prescribing guidelines for first-line therapy have also been updated to include dolutegravir and Triumeq.

    14 January 2015 | HIV i-Base
  • NAT opposes 50% cut to national HIV prevention funding for England

    The Government has announced that there will be devastating cuts to funding for the national HIV prevention programme in England.  Funding will be halved for the year commencing April 2015 and there is as yet no commitment to fund further years of the programme.  

    15 December 2014 | NAT press release
  • Save Our Service

    The Birmingham Heartlands HIV Service may be under threat as a result of the potential loss of our Sexual Health & GUM service. We need your help!

    12 December 2014 | Birmingham Heartlands HIV Service
  • National HIV Prevention Funding – An essential investment

    The Government is reducing funding for HIV prevention by 50% from 2015. There is no indication that HIV transmission rates in England are reducing and there continue to be major gaps in public understanding of how to prevent HIV. HIV prevention funding must remain at least at current levels.

    12 December 2014 | National AIDS Trust
  • ARV supply issues cause treatment interruptions in a UK clinic

    We have been told of ARV stock-outs that resulted in patients having to interrupt HIV medication due to problems in drug supply. It is difficult to understand why a UK clinic would allow problems to develop to the point that this happened not just once, but several times.

    01 December 2014 | HIV i-Base
  • Practical steps to eliminating hepatitis C: a consensus for London

    The aim of this document is to reinforce the need for urgent leadership from the Department of Health, PHE and NHS England and concerted action from Local Authorities, Health and Wellbeing Boards, Clinical Commissioning Groups (CCGs) and service providers to improve hepatitis C testing and treatment services in London for people with a history of using drugs – the group most affected by chronic hepatitis C – in order to find and treat significantly more people affected by the disease.

    17 November 2014 | London Joint Working Group on Substance Use and Hepatitis C
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.